Surgery remains a mainstay in the management of localized prostate cancer.
This article addresses surgical aspects germane to the management of men with prostate cancer, including patient selection for surgery, nerve-sparing approaches, minimization of positive surgical margins, and indications for pelvic lymph node dissection. Outcomes for men with high-risk prostate cancer following surgery are reviewed, and the present role of neoadjuvant therapy before radical prostatectomy is discussed. In addition, there is a review of the published literature on surgical ablative therapies for prostate cancer.
Written by:
Wright JL, Izard JP, Lin DW. Are you the author?
Department of Urology, University of Washington School of Medicine, 1959 Northeast Pacific, Seattle, WA 98195, USA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.
Reference: Hematol Oncol Clin North Am. 2013 Dec;27(6):1111-35.
doi: 10.1016/j.hoc.2013.08.010
PubMed Abstract
PMID: 24188255
UroToday.com Prostate Cancer Section
